George L. Sing - May 3, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
May 3, 2024
Transactions value $
$61
Form type
4
Date filed
5/6/2024, 04:20 PM
Previous filing
Feb 28, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $827K +2K +7.59% $413.33 28.3K May 3, 2024 Direct
transaction REGN Common Stock Tax liability -$827K -877 -3.09% $942.53 27.5K May 3, 2024 Direct
holding REGN Common Stock 750 May 3, 2024 by Spouse
holding REGN Common Stock 400 May 3, 2024 by Spouse/Cust Son
holding REGN Common Stock 1K May 3, 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -37.47% $0.00 3.34K May 3, 2024 Common Stock 2K $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.